Cargando…
Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.
We examined the ability of dipyridamole (DPM) to act synergistically with vinblastine (VBL) in HT1080 fibrosarcoma cells and a drug-resistant variant, HT1080/DR4, which lacks mdr1 expression, in order to determine whether DPM requires P-glycoprotein to modulate drug sensitivity. Median effect analys...
Autores principales: | Shalinsky, D. R., Slovak, M. L., Howell, S. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977708/ https://www.ncbi.nlm.nih.gov/pubmed/1680368 |
Ejemplares similares
-
Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.
por: Shalinsky, D. R., et al.
Publicado: (1993) -
Regulation of initial vinblastine influx by P-glycoprotein.
por: Shalinsky, D. R., et al.
Publicado: (1993) -
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
por: Chen, G K, et al.
Publicado: (2000) -
Dacarbazine/doxorubicin/vinblastine: Lack of efficacy: case report
Publicado: (2022) -
Long‐lasting Accumulation of Vinblastine in Inostamycin‐treated Multidrug‐resistant KB Cells
por: Kawada, Manabu, et al.
Publicado: (1991)